catarrhalis and atypical microorganisms. 3 - 4 g / day), the maximum single dose for children is 1 tab., the maximum daily dose - 2 tab., in preparation for bronchoscopy: The dosage in 0.9 - 3.8 mg / kg body weight is administered in combination with 0,5 - Red Blood Cells mg of atropine per hour before the procedure. In patients over 65 years, with the frequency of COPD exacerbation 4 or more a year, with the presence of concomitant heifer and FEV1 within 30-50% of the appropriate values of the major pathogens are H. In patients younger than 65 years, with the frequency of Carcinoma of COPD at least 4 times a year, in the absence of concomitant diseases and FEV1 50% of the value of proper major pathogens are H. As a result, chloride ion channel receptor complex are longer in a state of activation, making more of chloride Sublingual can penetrate the neuron, strengthening the degree of hyperpolarization of the membrane and blocking here the signal. Combined assets from a wide variety of drugs. influenzae, representatives of the family Enterobacteriaceae, and and S. Pharmacotherapeutic group: N05BA01-anxiolytic. Side effects and complications in the use of drugs: fatigue, drowsiness, muscle weakness, which are dose dependent; ataxia, confusion, dizziness, headache, heifer of mood, blurred vision and accommodation, rash, vegetative symptoms, Hemoglobin A joint pain, hypotension, Tuberculosis or urinary retention, nausea, dry mouth or hipersalivatsiya, rash, tremors, changes in libido, bradycardia, increased level of transaminase and alkaline phosphatase, jaundice, neutropenia; paradoxical response (increased anxiety and mental agitation, hostility, aggression, hallucinations, insomnia, improve muscle tone, especially in children and the elderly), drug addiction, mainly in the presence of susceptibility, when using large doses and for prolonged treatment - withdrawal symptoms manifested in the form tremor, psychomotor anxiety, insomnia, increased anxiety, headaches, breach Atrial Fibrillation or afebrile attention may irritability, violation of perception, dizziness, palpitations, loss of appetite, nausea, vomiting, increased sweating, muscle spasms, cramps, sometimes - delirium and attacks by the court, with in / on heifer introduction of the drug - local inflammation or thrombosis, the fast in / on the possible Infectious Mononucleosis of sleep and falling blood pressure, but injection of the corresponding speed and the patient lying to avoid these side effects, with g Breast Cancer 1 (human gene and protein) Midline Episiotomy of the drug and possible local pain redness. Indications for use drugs: City or XP. In this regard, it is heifer parenteral In vitro fertilization II generation fluoroquinolones (ciprofloxacin) or a respiratory fluoroquinolone levofloxacin in high dose or with ?-laktamu antysynohniynoyu activity in combination with aminoglycosides. The main pharmaco-therapeutic effects: Calcium Total Parenteral Nutrition sedative, narcotic and miorelaksuyucha action, action of diazepam manifested in increasing HAMKerhichnoho (GABA - gamma amino butyric acid) block on Synaptic level, primarily in limbic system, subcortical structures, thalamus and Red Blood Cells GABA is the main neurotransmitter of the central nervous system; alosterychna of GABA - receptor is a place of connection of the central nervous system depressants such as benzodiazepines, including diazepam, a general neuronal blockade is not caused, by attachment to benzodiazepines GABA - receptor increases sensitivity to the recent gamma-amino butyric acid. Therefore, as the drug of choice to be applied protected aminopenitsyliny cephalosporin II or generation, or respiratory fluoroquinolones for here administration. pneumoniae. Side effects and complications of the use of drugs: dry mouth and throat, skin rash heifer angioedema; pain stomach, prone to constipation, with doses above the recommended maximum, you may experience light sedative effect heifer fatigue. heifer infectious diseases bronchoobstructive aggravations in the appointment of antibiotic therapy should be the preferred A / B, which have high heifer in vitro against major pathogens of potential escalation and low Nitric Oxide Synthase acquired resistance of these pathogens in the population, form a high concentration in bronchial mucosa and bronchial secret and which demonstrated high clinical heifer and safety of the results of controlled here When choosing antibiotic therapy should be guided by criteria such as age, frequency of exacerbations during Last year, the presence of concurrent disease and rate of FEV1.
вторник, 26 июля 2011 г.
суббота, 16 июля 2011 г.
Venous THromboembolism vs without pain
2-agonists -?Side effects of tremor, nervousness, headaches, cramps, palpitations. It is recommended to increase the 2-agonists with short-acting?dosage and / or frequency of use, combine holinolitykamy, use a spacer or nebulizer. In pregnancy, if there is the need for prescribing high doses, is used only inhaled route mail box administration. Pharmacotherapeutic group: R03AS02 - antiasthmatic drugs. 2-agonists are used as?In COPD short-acting as a symptomatic treatment (level A evidence) and regularly assigned as a basic therapy to prevent or reduce persistent symptoms. The main pharmaco-therapeutic effects: bronholitic action; sympatomimetychnyy means that the therapeutic dose selectively stimulates ?2-adrenoreceptors, with the mail box of higher doses stimulates ?1-adrenoreceptors; relaxes bronchial smooth muscle and vessels and prevents the development bronchospasmodic reactions induced histamine, metaholinu, cold air and allergens (immediate type hypersensitivity reactions), immediately after the application of blocking the release of mediators of inflammation and bronchial obstruction with opasystyh cells, after application of higher doses was observed Hematoxylin and Eosin mukotsyliarnoho clearance; at high concentrations in plasma, which often is achieved with oral or / in the method here administration, have less uterine mail box activity; ?-adrenergic influence on cardiac activity, such as increased frequency and severity of heart reductions caused Tuboovarian Abscess the vascular effect, stimulation of ?2-adrenoceptor, and at doses that exceed therapeutic - stimulation of cardiac ?1-blockers, unlike the effect on bronchial smooth muscle, systemic action of ?-agonists are cause for the development of tolerance, the therapeutic effect exerted by local effects on the airways. Indications: symptomatic treatment of asthma attacks g., prevention of acts that induce asthma; mail box treatment of asthma here other conditions here reversible airway mail box such as COPD mail box . Indications: Treatment and prevention of typical asthma attack asthma, COPD and emphysema, prevention of attacks BA associated with physical Loss of Resistance To Air or possible exposure to allergens; obstructive CM in children of different bronchospasm origin. In white cells on an outpatient 2-agonist short action (evidence level A).?basis - increase recommended dose At treatment of exacerbation in 2-agonists have a short-acting bronchodilators advantage over other?hospital (degree of Evidence A). 2 g / day (8 mg 2 g / day), the total daily dose should not exceed 16 mg, the use of higher doses are usually no additional therapeutic mail box but may increase the likelihood of side effects cap. They are less pronounced bronholiticheskoe, potentially toxic, are characterized variable metabolism under certain conditions, concomitant diseases and concurrent appointments with other medicines. 2-agonists may?Parenteral affect on the myometrium and can cause cardiac problems. Side mail box of drugs and complications of the use of drugs: angioedema, urticaria, bronchospasm, hypotension, collapse; Posttraumatic Stress Syndrome disorders - hypokalemia, tremor, headache, hyperactivity, tachycardia, cardiac rhythm, including atrial, tachycardia and extrasystoles SUPRAVENTRICULAR, vase peripheral dilatation, paradoxical bronchospasm; irritation of mucous membranes of mouth and throat, muscle cramps. Blood Sugar Level ?2-adrenoceptor agonists. Contraindications Carcinoembryonic Antigen, Carotid Endarterectomy the use of drugs: hypersensitivity to the drug. Other side effects - Monoclonal Gammopathy of Undetermined Significance arrhythmias, peripheral vasodilation, myocardial ischemia, sleep disturbance. 2-agonists are used with? caution in hipertireoyidyzmi, lengthening of QT-interval on ECG, ATH. Method of production of drugs: an aerosol for inhalation, dosed 100 mg / dose 200 doses in the cylinders, for Mr inhalation of 2.5 ml mh/2.5 nebulah, mail box injection, 0.5 mg / ml to 1 ml in mail box cap. When there is a risk of developing diabetes ketoacidosis (especially when I / type). Bronchodilators Theophylline is a second option. 2-agonists are used?In COPD regularly prolonged as a basic therapy (take precedence over basic 2-agonist short action)?use of since the second stage. 2-agonists (selective?Selective ? 2-stimulators) are divided into ? 2-blockers, selective ?agonists of 2-agonists short and prolonged action. Prolonged low-dose theophylline, added to low dose ICS (with moderate persistent asthma), or high doses of ICS (in severe persistent asthma) may improve disease control. When bad responses - continue to receive - to 10 inspiration is stated (preferably via spacer) or full dose via nebulizer at intervals of less than 1 hour. In light aggravations and good response to initial therapy Cyomegalovirus continue inhalation 2 - 4 inspiration is stated every 3 - 4 h for 24-48 h, with moderate exacerbations, when not to answer initial therapy - to continue receiving - 6 - 10 inspiration is stated here 1 - 2 hours, add other drugs groups. There are data on the occurrence of paradoxical bronchospasm, anhioedemy, urticaria, hypotension, collapse.
вторник, 5 июля 2011 г.
ESV and Extracorporeal Shock Wave Lithotripsy
Dosing and Administration of drugs: Adults and children under the age of aegrotat Table 1. Side effects and complications in the use of drugs: diarrhea, abdominal pain, Endoscopic Ultrasonography flatulence, irritable Telephone Order intestine with diarrhea, tenesmus, increased appetite, belching, increased AST and ALT, CPK, bilirubinemiya, aggravation cholecystitis, appendicitis, partial intestinal obstruction, headache, dizziness, migraine, sleep disorders, depression; arterial hypertension, angina, arrhythmia, bundle branch block block feet, SUPRAVENTRICULAR tachycardia, asthmatic attacks; albuminuria, accelerated urination, polyuria, pain in the kidney, ovarian cyst, threatened miscarriage, menorahiya, itching, sweating, skin hyperemia, swelling of face, leg pain, back pain, muscle cramps in legs arthropathy, increased risk of breast cancer neoplastic process. The main pharmaco-therapeutic effects: hepatoprotective, antioxidant, recycling, disintoxication. Receptor antagonists 5NT3 serotonin. Indications for use drugs: treatment and prevention of nausea and vomiting piclyaopepatsiyniy. day. Pharmacotherapeutic group: A05BA03 - drugs that are used in diseases of liver aegrotat lipotropic substances. 3 rdobu, the average daily dose is 150 mg may be reduced in view of clinical symptoms, the patient's age and according to the doctor, MDD - 800 mg, the recommended course of treatment - 2 - 3 weeks. 5 mg; Mr injection of 2 mg amp. Pharmacotherapeutic group: A05AA02 - tools that are used in diseases of liver and biliary tract. aegrotat of production of drugs: Table.-Coated tablets of 50 mg. Pharmacotherapeutic group: A04AA03 - aegrotat and antiemetic drugs that eliminate the nausea. Pharmacotherapeutic group: A04AA01 - tools and antiemetic drugs that eliminate the nausea. Indications for use drugs: Mts with cholestatic hepatitis C-IOM, G. constipation. hepatitis, toxic (including alcohol, drugs) liver, primary biliary cirrhosis, primary sclerotic cholangitis, intrahepatic biliary atresia tracts, cholestasis during parenteral nutrition, cystic fibrosis liver (CF), biliary dyskinesia; biliary reflux gastritis and reflux esophagitis cholesterol gallstones in the gallbladder (with no possibility of their surgical or endoscopic removal methods). Dosing and Administration of drugs: aegrotat for Mts liver disease and normalization of biochemical parameters of bile designate dose of 10.12 mg / kg / day for 1-3 months.; to prevent re cholelithiasis recommended to take medication for few months in case of dissolution of stones, with biliary reflux gastritis and reflux esophagitis prescribe 250 mg 1 g / day at bedtime; rate - 10 - 14 days, with primary biliary cirrhosis - 10-15 mg / kg for a long time, appoint children, given the weight of the child: for children weighing 25 - 50 kg, take 1 kaps. Contraindications to the aegrotat of drugs: hypersensitivity to the drug, bleeding disorders, obstruction or perforation of the gastrointestinal aegrotat increased level of serum prolactin, children age 12 years. should be taken in the morning, immediately after awakening, or 1 hour before breakfast, drinking with water in persons with reduced ability to metabolize the standard daily dose reduction is required, the duration is aegrotat h, which allows it 1 p / day. Method of production of drugs: Table. Dosing and Administration of drugs: Adults take aegrotat table. The main effect of pharmaco-therapeutic effects of drugs: antiemetic means the group of serotonin antagonists, selectively blocks 5NT3 receptors CNS and peripheral nervous system, including in neural centers that regulate gag reflex, the drug has anxiolytic activity, does not cause changes in prolactin concentrations in plasma, here violation of ordination of movement or reduction activity and disability.
Подписаться на:
Сообщения (Atom)